{"timestamp": 1771604710.903071, "value": {"ticker": "OSTX", "company_name": "OS Therapies Incorporated", "short_name": "OS Therapies Incorporated", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 42549500, "float_shares": 26884045, "shares_outstanding": 35214352, "short_ratio": 1.41, "short_percent_of_float": 0.030199999, "shares_short": 965726, "shares_short_prior": 623422, "insider_percent_held": 0.27997, "institution_percent_held": 0.05286, "total_cash": 1876626, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 0.56, "book_value": 0.109, "price_to_book": 11.085321, "operating_cashflow": -12882907, "free_cashflow": -7755321, "price": 1.2083, "52w_high": 2.57, "52w_low": 1.12, "avg_volume": 540028, "avg_volume_10d": 662130, "full_time_employees": 4, "audit_risk": 0, "overall_risk": 0}}